UnitedHealth Group Incorporated (NYSE:UNH) is High Note Wealth LLC’s 7th Largest Position

High Note Wealth LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,173 shares of the healthcare conglomerate’s stock after buying an additional 89 shares during the quarter. UnitedHealth Group accounts for about 3.9% of High Note Wealth LLC’s holdings, making the stock its 7th biggest holding. High Note Wealth LLC’s holdings in UnitedHealth Group were worth $13,549,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently bought and sold shares of the stock. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the period. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter worth approximately $31,000. Finally, Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $591.22 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a market capitalization of $545.94 billion, a P/E ratio of 36.14, a P/E/G ratio of 1.65 and a beta of 0.58. The company’s fifty day moving average is $582.68 and its two-hundred day moving average is $529.13. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm earned $6.14 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on UNH. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday, October 1st. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. HSBC raised their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, Royal Bank of Canada raised their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.